The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Novartis Ireland Limited naming Frances Fitzgerald .

Filed returns
4
match these filters
Matching filed returns per period 0 0 1 1 2 May–Aug 2016: 1 filed returns May–Aug 2017: 1 filed returns Sep–Dec 2020: 2 filed returns
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Sep–Dec 2020 Novartis Ireland Limited Health Expansion of Newborn Screening (Legislation) 2 On lobbying.ie
Sep–Dec 2020 Novartis Ireland Limited Health Timely access to innovative new products, IP, EU Pharma Strategy (Legislation) 1 On lobbying.ie
May–Aug 2017 Novartis Ireland Limited Health Highlight delay in reimbursing Entresto (Heart Failure medine), the first new innovation in heart failure in a decade considered cost effective in July 2016 (Matters involving public funds) 23 On lobbying.ie
May–Aug 2016 Novartis Ireland Limited Health Ensure that the 2016 Framework Agreement on the Pricing and Supply of Medicines is resolved by aggreement, not legislation (Public policy or programme) 5 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 4 100.0%